Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference

About this update from Vir Biotechnology, Inc.

SAN FRANCISCO --(BUSINESS WIRE)-- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4 at 8:50 a.m. PT / 11:50 a.m. ET in Boston, Massachusetts . A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website and will be archived for 30 days. About Vir Biotechnology Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website. View source version on businesswire.com : https://www.businesswire.com/news/home/20250219968347/en/ Media Arran Attridge Senior Vice President, Corporate Communications [email protected] Investors Richard Lepke Senior Director, Investor Relations [email protected] Source: Vir Biotechnology, Inc.

View stock analysis, news, and events for Vir Biotechnology, Inc.